Ruxolitinib as first-line therapy in secondary hemophagocytic lymphohistiocytosis and HIV infection
Sergio Gálvez Acosta, Mariana Javalera Rincón
Topics & Concepts
Hemophagocytic lymphohistiocytosisMedicineRuxolitinibImmunologyHemophagocytosisHematologyInternal medicineDiseaseBone marrowPancytopeniaMyelofibrosisAutoimmune and Inflammatory Disorders ResearchParvovirus B19 Infection StudiesImmune Cell Function and Interaction